Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Fibroblast Growth Factor-23 (FGF-23) is Independently Associated With Left Ventricular Mass Index (LVMI) and Myocardial Performance Index (MPI) in Haemodialysis Patients

The recruitment status of this study is unknown because the information has not been verified recently.
Verified January 2010 by Diskapi Teaching and Research Hospital.
Recruitment status was  Active, not recruiting
Information provided by:
Diskapi Teaching and Research Hospital Identifier:
First received: June 30, 2010
Last updated: July 12, 2010
Last verified: January 2010
No Study Results Posted on for this Study
  Study Status: This study is ongoing, but not recruiting participants.
  Estimated Study Completion Date: June 2010
  Estimated Primary Completion Date: May 2010 (Final data collection date for primary outcome measure)